Skip to main content
Research project

CRUK - Targeting Myeloid Cells For Improved Antibody Immunotherapy - DRCRPG-May23/100001

Staff

Lead researcher

Professor Mark Cragg

Professor in Experimental Cancer Biology

Research interests

  • Antibody biology
  • Antibody engineering
  • Cancer Immunotherapy
Other researchers

Dr Stephen Thirdborough

Senior Research Fellow

Professor Stephen Beers

Professor of Immunology & Immunotherapy

Professor Jon Strefford PhD

Head of School

Dr Matthew Carter

Senior Research Fellow

Professor Sean Lim

Professor of Haematology

Research interests

  • Identification of new therapeutic targets in lymphoma
  • Development of novel monoclonal antibody combination therapies for cancer
  • Understanding the determinants of an effective immune response in patients with lymphoma

Dr Jonathan West

Associate Professor

Research interests

  • Platelet Diversity The lab has a keen interest in understanding the nature and consequences of platelet functional diversity. Using a droplet microfluidics strategy we can measure intrinsic platelet behaviour. Broad-continuum sensitivity was identified, with hypersensitive platelets able to drive heterotypic system polarisation. Current research aims at characterising platelet dynamics and transcriptome remodelling in response to stimulation to pin-point sub-populations governing thrombosis.

Dr Yury Bogdanov

Lecturer in Transgenic Technologies

Research interests

  • Tumour microenvironment
  • Neurotransmitters in Cancer
  • GABA and GABA receptors
Back
to top